Resolution passes at World Health Assembly, calling for more affordable vaccines and greater transparency on vaccine pricing
Last updated 25 May 2015
On 13 May, TB Alliance announced the start of its Nix-TB (New Investigational Drugs for XDR-TB) clinical trial, the first to test a new all-oral regimen for extensively drug-resistant tuberculosis (XDR-TB). Background...
Last updated 13 May 2015
WHO announcement: WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers “The essential medicines list (EML) is an essential tool for countries, regulators...
Last updated 12 May 2015
MSF and DNDi Join Call for a Biomedical Research and Development Fund and Mechanism to Meet Pressing Global Health Needs
Last updated 11 May 2015
Thousands of activists urge company to change its policies on eve of shareholder meeting New York, May 5, 2015 — On the eve of pharmaceutical company Gilead Sciences’ annual shareholder meeting,...
Last updated 5 May 2015
WHO announcement: An initiative to extend access to a new TB drug Background information:
Last updated 29 April 2015
Last updated 23 April 2015
Last updated 13 April 2015
As first EU Ministerial meeting on tuberculosis closes, MSF calls on the EU to triple funding for TB R&D
As the first-ever Eastern Partnership Ministerial Conference on Tuberculosis and Multidrug-Resistant Tuberculosis concludes in Riga, Latvia today, Médecins Sans Frontières (MSF) calls on the European...
Last updated 31 March 2015
MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week
Last updated 24 March 2015